Achieve Life Sciences Inc (ACHV) |
|
8.87 -0.4 (-4.32%)
|
08-13 16:00 |
|
Open: |
9.28 |
Pre. Close: |
9.27 |
|
High:
|
9.29 |
Low:
|
8.63 |
|
Volume:
|
377,918 |
Market Cap:
|
32M |
|
|
|
|
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. Its product candidate include cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. The company has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. Achieve Life Sciences, Inc. was incorporated in 1991 and is based in Vancouver, Canada. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.3 - 9.376 |
9.376 - 9.427 |
|
Low:
|
8.48 - 8.56 |
8.56 - 8.613 |
|
Close:
|
8.764 - 8.889 |
8.889 - 8.974 |
|
Technical analysis |
as of: 2020-08-13 4:31:13 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 16.48 One year: 21.33 |
| Support: |
Support1: 7.40 Support2: 6.16 |
| Resistance: |
Resistance1: 14.11 Resistance2: 18.26 |
| Pivot: |
11.11  |
| Moving Average: |
MA(5): 10.02 MA(20): 10.71 
MA(100): 8.42 MA(250): 16.13 |
| MACD: |
MACD(12,26): 0.27 Signal(9): 0.63 |
| Stochastic oscillator: |
%K(14,3): 6.15 %D(3): 13.60 |
| RSI: |
RSI(14): 43.70 |
| 52-week: |
High: 50.20 Low: 4.60 Change(%): -75.5 |
| Average Vol(K): |
3-Month: 159751 10-Days: 134122 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ACHV has closed above bottom band by 10.6%. Bollinger Bands are 119.7% wider than normal. The large width of the bands suggest high volatility as compared to ACHV's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Sun, 09 Aug 2020
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
Tue, 04 Aug 2020
Achieve Life Sciences Announces Pricing of $6.5 Million Public Offering - PRNewswire
Tue, 04 Aug 2020
Achieve Life Sciences prices equity offering at $10.50/share - Seeking Alpha
Mon, 03 Aug 2020
Achieve Life Sciences Announces Proposed Public Offering - PRNewswire
Fri, 31 Jul 2020
Achieve Announces Patent Granted in the US for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications - PRNewswire
Thu, 30 Jul 2020
ACHIEVE LIFE SCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.com
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
38 |
| Shares Float (M) |
37 |
|
% Held by Insiders
|
1.13 |
|
% Held by Institutions
|
17.06 |
|
Shares Short (K)
|
2,180 |
|
Shares Short P. Month (K)
|
1,000 |
Stock Financials |
|
EPS
|
-0.441 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.480 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-56.0 |
|
Return on Equity (ttm)
|
-109.7 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.365 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-15 |
|
Levered Free Cash Flow (M)
|
-10 |
Stock Valuations |
|
PE Ratio
|
-20.11 |
|
PEG Ratio
|
|
|
Price to Book value
|
18.48 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-22.50 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
